-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Verve Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q2 2024.
- Verve Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 84.2M shares, a 36% increase year-over-year.
- Verve Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 64.2M shares, a 18.8% increase from 2022.
- Verve Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 54M shares, a 101% increase from 2021.
- Verve Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 26.9M shares, a 1094% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)